Cartesian Therapeutics
RNAC
#6732
Rank
S$0.62 B
Marketcap
$26.02
Share price
3.61%
Change (1 day)
-41.69%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2024 (TTM): -S$0.33 Billion

According to Cartesian Therapeutics's latest financial reports the company's current earnings are S$54.1 Million. In 2023 the company made an earning of -S$0.31 Billion a decrease over its 2022 earnings that were of S$49.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.33 Billion5.88%
2023 -S$0.31 Billion-724%
2022 S$49.67 M-649.67%
2021 -S$9.04 Million-89.78%
2020 -S$88.47 Million25.06%
2019 -S$70.74 Million-15.68%
2018 -S$83.9 Million-0.43%
2017 -S$84.26 Million83.41%
2016 -S$45.94 Million44.3%
2015 -S$31.84 Million